TFC timeline
Every TFC batch the index holds, newest manufacture date first, with the supplier's declared purity beside the median of the index's independent observations of the same lot.
| Lot | Compound | Manufactured | Quarter | Tests | Independent median | Spread (pp) | COA purity | Divergence (pp) | |
|---|---|---|---|---|---|---|---|---|---|
| TFC-2608-J1156 | Retatrutide | 25 Aug 2026 | 2026-Q3 | 3 | 98.42 | 0.27 | 98.42 | 0.00 | |
| TFC-2608-S9940 | Humanin (HNG) | 12 Aug 2026 | 2026-Q3 | 7 | 98.50 | 0.38 | 98.22 | -0.28 | |
| TFC-2607-R9099 | SS-31 (Elamipretide) | 20 Jul 2026 | 2026-Q3 | 7 | 99.61 | 0.39 | 99.90 | +0.29 | |
| TFC-2605-H2745 | Enclomiphene citrate | 29 May 2026 | 2026-Q2 | 1 | 99.41 | n<2 | 99.66 | +0.25 | |
| TFC-2605-R9506 | MOTS-c | 26 May 2026 | 2026-Q2 | 5 | 99.23 | 0.37 | 99.01 | -0.22 | |
| TFC-2605-U1300 | Humanin (HNG) | 23 May 2026 | 2026-Q3 | 5 | 99.52 | 0.66 | 99.27 | -0.25 | |
| TFC-2605-G9870 | Tirzepatide | 23 May 2026 | 2026-Q3 | 4 | 98.41 | 0.78 | 98.56 | +0.15 | |
| TFC-2605-Y2176 | Sermorelin | 16 May 2026 | 2026-Q3 | 4 | 99.15 | 1.38 | 99.01 | -0.14 | |
| TFC-2605-P3253 | CJC-1295 with DAC | 02 May 2026 | 2026-Q2 | 1 | 99.27 | n<2 | 99.43 | +0.16 | SHARED BULK |
| TFC-2604-A9366 | BPC-157 | 26 Apr 2026 | 2026-Q2 | 4 | 99.55 | 0.16 | 99.14 | -0.41 | |
| TFC-2604-X9037 | Semaglutide | 17 Apr 2026 | 2026-Q3 | 5 | 98.95 | 1.27 | 99.22 | +0.27 | |
| TFC-2604-Y3208 | SS-31 (Elamipretide) | 14 Apr 2026 | 2026-Q3 | 1 | 99.68 | n<2 | 99.72 | +0.04 | |
| TFC-2604-B2419 | Kisspeptin-10 | 03 Apr 2026 | 2026-Q2 | 11 | 99.24 | 0.73 | 99.25 | +0.01 | |
| TFC-2603-M2502 | Ipamorelin | 19 Mar 2026 | 2026-Q2 | 4 | 99.88 | 0.35 | 99.90 | +0.02 | |
| TFC-2602-F9327 | Semax | 16 Feb 2026 | 2026-Q2 | 2 | 99.47 | 0.32 | 99.87 | +0.40 | |
| TFC-2602-H9925 | Semaglutide | 09 Feb 2026 | 2026-Q1 | 13 | 99.05 | 1.24 | 98.43 | -0.62 | |
| TFC-2601-L2937 | Afamelanotide | 02 Jan 2026 | 2026-Q2 | 1 | 99.06 | n<2 | 99.90 | +0.84 | |
| TFC-2511-N1358 | MK-677 (Ibutamoren mesylate) | 27 Nov 2025 | 2025-Q4 | 4 | 99.18 | 0.75 | 98.51 | -0.67 | |
| TFC-2511-E2264 | Liraglutide | 13 Nov 2025 | 2026-Q2 | 1 | 99.12 | n<2 | 99.25 | +0.13 | SHARED BULK |
| TFC-2511-S9305 | BPC-157 | 06 Nov 2025 | 2026-Q2 | 8 | 98.72 | 0.75 | 99.40 | +0.68 | SHARED BULK |
| TFC-2511-L1212 | AOD-9604 | 06 Nov 2025 | 2025-Q4 | 1 | 99.93 | n<2 | 99.79 | -0.14 | |
| TFC-2511-C2146 | Selank | 06 Nov 2025 | 2025-Q4 | 1 | 99.56 | n<2 | 99.50 | -0.06 | |
| TFC-2511-E2186 | Gonadorelin | 03 Nov 2025 | 2026-Q2 | 2 | 99.70 | 0.10 | 99.80 | +0.10 | |
| TFC-2511-E9934 | Epitalon | 02 Nov 2025 | 2026-Q1 | 7 | 99.93 | 0.45 | 99.90 | -0.03 | |
| TFC-2508-M9624 | KPV | 29 Aug 2025 | 2026-Q1 | 7 | 99.93 | 0.39 | 99.90 | -0.03 | |
| TFC-2508-L1799 | Retatrutide | 29 Aug 2025 | 2025-Q3 | 2 | 98.29 | 0.96 | 98.55 | +0.26 | |
| TFC-2508-W1453 | BPC-157 | 25 Aug 2025 | 2025-Q3 | 7 | 99.81 | 0.33 | 99.90 | +0.09 | |
| TFC-2508-L2057 | 5-Amino-1MQ | 22 Aug 2025 | 2026-Q1 | 5 | 99.75 | 0.53 | 99.50 | -0.25 | |
| TFC-2508-H1748 | IGF-1 LR3 | 20 Aug 2025 | 2025-Q3 | 11 | 97.86 | 1.10 | 97.54 | -0.32 | |
| TFC-2508-V8915 | Retatrutide | 19 Aug 2025 | 2026-Q1 | 16 | 98.64 | 1.29 | 98.75 | +0.11 | |
| TFC-2508-A1033 | Semaglutide | 17 Aug 2025 | 2026-Q1 | 4 | 99.15 | 0.90 | 98.91 | -0.24 | |
| TFC-2508-W1380 | Epitalon | 15 Aug 2025 | 2026-Q1 | 7 | 99.01 | 0.58 | 99.50 | +0.49 | |
| TFC-2508-L2482 | Tirzepatide | 09 Aug 2025 | 2026-Q1 | 8 | 98.15 | 0.60 | 98.27 | +0.12 | |
| TFC-2508-G1453 | Tirzepatide | 08 Aug 2025 | 2025-Q3 | 11 | 99.20 | 1.36 | 99.16 | -0.04 | |
| TFC-2507-C9225 | CJC-1295 (no DAC) | 17 Jul 2025 | 2025-Q4 | 9 | 99.34 | 0.81 | 99.90 | +0.56 | |
| TFC-2507-M8937 | PEG-MGF | 09 Jul 2025 | 2025-Q3 | 2 | 97.75 | 0.60 | 98.11 | +0.36 | |
| TFC-2507-J2316 | BPC-157 | 08 Jul 2025 | 2025-Q3 | 8 | 98.96 | 0.70 | 99.50 | +0.54 | |
| TFC-2507-T1116 | Tirzepatide | 07 Jul 2025 | 2025-Q3 | 12 | 97.88 | 1.03 | 98.28 | +0.40 | |
| TFC-2507-U1178 | Semaglutide | 01 Jul 2025 | 2025-Q4 | 4 | 99.28 | 0.59 | 99.61 | +0.33 | |
| TFC-2505-A9766 | Selank | 27 May 2025 | 2025-Q4 | 2 | 98.90 | 0.30 | 99.40 | +0.50 | |
| TFC-2505-C1792 | NAD+ | 20 May 2025 | 2025-Q3 | 5 | 99.52 | 0.56 | 99.77 | +0.25 | |
| TFC-2505-H2637 | Semax | 15 May 2025 | 2025-Q4 | 12 | 99.74 | 0.66 | 99.90 | +0.16 | |
| TFC-2504-J2701 | BPC-157 | 24 Apr 2025 | 2025-Q2 | 1 | 99.43 | n<2 | 99.84 | +0.41 | |
| TFC-2504-G2332 | Selank | 17 Apr 2025 | 2025-Q3 | 11 | 99.24 | 0.81 | 98.99 | -0.25 | |
| TFC-2503-E9984 | VIP | 27 Mar 2025 | 2025-Q2 | 3 | 98.95 | 0.46 | 98.49 | -0.46 | |
| TFC-2503-R1539 | TB-500 | 25 Mar 2025 | 2025-Q3 | 3 | 99.40 | 0.44 | 99.03 | -0.37 | |
| TFC-2503-C3112 | MOTS-c | 23 Mar 2025 | 2025-Q3 | 2 | 99.16 | 0.06 | 99.29 | +0.13 | |
| TFC-2503-L9791 | TB-500 | 15 Mar 2025 | 2025-Q3 | 5 | 99.33 | 0.40 | 99.15 | -0.18 | |
| TFC-2502-L2101 | Semaglutide | 27 Feb 2025 | 2025-Q1 | 3 | 98.24 | 0.30 | 98.17 | -0.07 | |
| TFC-2502-Y2346 | Afamelanotide | 26 Feb 2025 | 2025-Q1 | 14 | 99.23 | 0.62 | 99.00 | -0.23 | |
| TFC-2502-D2333 | GHRP-2 | 09 Feb 2025 | 2025-Q1 | 12 | 99.63 | 0.61 | 99.38 | -0.25 | |
| TFC-2501-K2935 | ARA-290 | 29 Jan 2025 | 2025-Q2 | 5 | 99.93 | 0.11 | 99.90 | -0.03 | |
| TFC-2412-A1938 | TB-500 | 12 Dec 2024 | 2025-Q1 | 1 | 99.81 | n<2 | 99.29 | -0.52 | |
| TFC-2411-R1539 | Adipotide | 29 Nov 2024 | 2025-Q2 | 2 | 98.80 | 0.34 | 98.84 | +0.04 | |
| TFC-2411-M9928 | CJC-1295 (no DAC) | 21 Nov 2024 | 2025-Q2 | 7 | 99.03 | 0.73 | 98.54 | -0.49 | |
| TFC-2411-A2083 | GHRP-2 | 19 Nov 2024 | 2025-Q1 | 11 | 99.78 | 0.41 | 99.40 | -0.38 | |
| TFC-2410-F1982 | SS-31 (Elamipretide) | 29 Oct 2024 | 2024-Q4 | 7 | 99.33 | 0.88 | 99.42 | +0.09 | |
| TFC-2410-R2237 | Melanotan II | 19 Oct 2024 | 2025-Q1 | 3 | 99.25 | 0.22 | 99.66 | +0.41 | |
| TFC-2410-N1098 | ARA-290 | 09 Oct 2024 | 2024-Q4 | 1 | 99.85 | n<2 | 99.90 | +0.05 | |
| TFC-2409-U2263 | Dihexa | 30 Sep 2024 | 2025-Q1 | 2 | 99.92 | 0.02 | 99.85 | -0.07 | |
| TFC-2409-S3094 | Semaglutide | 26 Sep 2024 | 2024-Q4 | 8 | 99.02 | 0.62 | 99.65 | +0.63 | |
| TFC-2409-H3000 | Retatrutide | 19 Sep 2024 | 2024-Q4 | 5 | 97.70 | 0.75 | 97.87 | +0.17 | SHARED BULK |
| TFC-2409-Y1996 | Survodutide | 18 Sep 2024 | 2025-Q1 | 2 | 99.13 | 0.28 | 98.70 | -0.43 | |
| TFC-2409-W1685 | Exenatide | 17 Sep 2024 | 2024-Q4 | 1 | 99.93 | n<2 | 99.90 | -0.03 | |
| TFC-2408-T9161 | Ipamorelin | 31 Aug 2024 | 2025-Q1 | 5 | 98.99 | 0.51 | 99.17 | +0.18 | |
| TFC-2406-P1877 | IGF-1 LR3 | 10 Jun 2024 | 2024-Q4 | 5 | 97.69 | 0.31 | 97.82 | +0.13 | |
| TFC-2406-A1769 | 5-Amino-1MQ | 06 Jun 2024 | 2024-Q4 | 5 | 99.14 | 0.68 | 99.00 | -0.14 | |
| TFC-2405-W1499 | Tirzepatide | 03 May 2024 | 2024-Q2 | 1 | 97.98 | n<2 | 97.64 | -0.34 | |
| TFC-2404-J9626 | Enclomiphene citrate | 24 Apr 2024 | 2024-Q3 | 11 | 99.44 | 0.97 | 99.10 | -0.34 | |
| TFC-2404-U1948 | Tirzepatide | 11 Apr 2024 | 2024-Q2 | 2 | 98.94 | 0.19 | 99.18 | +0.24 | |
| TFC-2402-L2242 | AOD-9604 | 12 Feb 2024 | 2024-Q2 | 5 | 99.19 | 0.66 | 98.77 | -0.42 | |
| TFC-2402-N9576 | Kisspeptin-10 | 10 Feb 2024 | 2024-Q3 | 3 | 99.40 | 0.52 | 99.66 | +0.26 | |
| TFC-2401-J9617 | Melanotan II | 03 Jan 2024 | 2024-Q2 | 2 | 99.40 | 0.04 | 99.87 | +0.47 | |
| TFC-2312-P3229 | Tirzepatide | 12 Dec 2023 | 2024-Q2 | 7 | 98.12 | 0.75 | 98.51 | +0.39 | |
| TFC-2310-J1196 | PT-141 (Bremelanotide) | 05 Oct 2023 | 2024-Q1 | 11 | 99.93 | 0.23 | 99.90 | -0.03 | |
| TFC-2309-H2397 | Retatrutide | 26 Sep 2023 | 2024-Q1 | 17 | 98.63 | 0.57 | 99.90 | +1.27 |